Sanjay Gandhi Postgraduate Institute of Medical Sciences is a medical Institute under State Legislature Act, located in Lucknow, Uttar Pradesh 14 km south of Hazratganj on Raebareli road. It was established in 1983 and is named after Sanjay Gandhi. The institute is on a 550 acres residential campus at Raebareli Road.

During the past decade, Sanjay Gandhi Postgraduate Institute of Medical Sciences conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" #1 sponsor was "Sanjay Gandhi Postgraduate Institute of Medical Sciences" with 14 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pharmazz, Inc." with 2 trials sponsored and "The George Institute" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" #1 collaborator was "Abbott Healthcare Private Limited (in India)" with 1 trials as a collaborator, "Alberta Children's Hospital" with 1 trials as a collaborator, "American Society of Clinical Oncology" with 1 trials as a collaborator, "Armed Forces Medical College, Pune" with 1 trials as a collaborator and "Army Hospital Research and Referral, New Delhi" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" are "Coronary Artery Disease" (3 trials), "Coronary Artery Stenosis" (2 trials), "Myocardial Ischemia" (2 trials), "Acute Stroke" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" are "Drug" (30 trials), "Other" (8 trials), "Device" (5 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Baricitinib" (2 trials), "Normal Saline along with standard treatment" (2 trials), "Observational study" (2 trials) and "Rifaximin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanjay Gandhi Postgraduate Institute of Medical Sciences" are 42 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sanjay Gandhi Postgraduate Institute of Medical Sciences". undefined are not yet recruiting, 10 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Sanjay Gandhi Postgraduate Institute of Medical Sciences, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sanjay Gandhi Postgraduate Institute of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".

Sanjay Gandhi Postgraduate Institute of Medical Sciences has several departments that took part in Clinical trials: "Department of Critical Care Medicine, SGPGIMS" - 6 trials